Clinical Pharmacogenetic of Ibuprofen After Lower Third Molar Surgeries
NCT03169127 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2019-07-12
Summary
The present clinical trial randomized will be to assess the link between the different haplotypes of CYP2C8 and CYP2C9 genes and the clinical efficacy of ibuprofen after lower third molar extractions. Onset, duration of postoperative analgesia, duration of anesthetic action on soft tissues, intraoperative bleeding, hemodynamic parameters, postoperative mouth opening and wound healing at the 7th postoperative day were evaluated. For this purpose, 200 healthy volunteers underwent removal of one lower third molar, under local anesthesia with articaine 4% (1:200,000 adrenaline) will be genotyped and phenotyped for these genes and their postoperative records with all data collected will be compared with the haplotypes found in the Brazilian population.
Conditions
- Pain
- Other Surgical Procedures
- Impacted Third Molar Tooth
Interventions
- DRUG
-
Ibuprofen 600 mg
After lower third molars surgeries, pharmacogenetic and clinical efficacy of Ibuprofen 600mg was study.
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Sao Paulo
lead OTHER
Principal Investigators
-
Giovana M Weckwerth, DDS · 416.016.638-54
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-01
- Primary Completion
- 2018-07-30
- Completion
- 2020-07-01
Countries
- Brazil
Study Locations
More Related Trials
-
Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain
NCT01929031 ·Status: COMPLETED ·Phase: PHASE3
-
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
NCT05919745 ·Status: RECRUITING ·Phase: PHASE4
-
A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain
NCT02912650 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching
NCT01530217 ·Status: COMPLETED ·Phase: NA
-
the Effect of Preoperative Sodium Ibuprofen on Postoperative Endodontic Pain
NCT04964622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet
NCT02902289 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg
NCT05329454 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects
NCT02256423 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain
NCT01559259 ·Status: COMPLETED ·Phase: PHASE2
-
To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet
NCT02629354 ·Status: COMPLETED ·Phase: PHASE1
-
An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain
NCT00240864 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers
NCT02182960 ·Status: COMPLETED ·Phase: PHASE1
-
An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.
NCT00240825 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination
NCT05428306 ·Status: COMPLETED ·Phase: PHASE1
-
Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers
NCT03722238 ·Status: TERMINATED ·Phase: PHASE3
-
Study Comparing the Efficacy of Two Ibuprofen Formulations
NCT00740857 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain
NCT05013567 ·Status: UNKNOWN ·Phase: PHASE3
-
Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet
NCT02902302 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.
NCT01466517 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers
NCT03418805 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
NCT01373697 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.
NCT04429282 ·Status: UNKNOWN ·Phase: PHASE3
-
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
NCT01789606 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
NCT07036861 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients
NCT01131000 ·Status: COMPLETED ·Phase: PHASE3